CEFOBID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefobid, and what generic alternatives are available?
Cefobid is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in CEFOBID is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Summary for CEFOBID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 1 |
Patent Applications: | 4,560 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFOBID at DailyMed |
Recent Clinical Trials for CEFOBID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
RenJi Hospital | Phase 4 |
Erzhen Chen | Phase 4 |